FDA Inspection 1203488 — BOLIVE INC
The FDA completed an inspection of BOLIVE INC on Apr 17, 2023 in Los Angeles, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 5 citations were issued during this inspection. Product area: Food/Cosmetics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Apr 17, 2023
- Fiscal Year
- 2023
- Product Type
- Food/Cosmetics
- Project Area
- Foodborne Biological Hazards
- Location
- Los Angeles, CA (United States)
Additional Details
FSVP
Citations
| ID | CFR | Description |
|---|---|---|
| 18262 | 21 CFR 1.504(a) | Hazard analysis written |
| 18281 | 21 CFR 1.505(a)(2) | Evaluation - performance, risk |
| 18290 | 21 CFR 1.506(a)(1) | Approved supplier procedures - importer established |
| 18303 | 21 CFR 1.506(e)(1) | Verification activity before import, periodically |
| 18325 | 21 CFR 1.508(b) | Investigate |